“These products are now federally recognized as legitimate medicine… Patients and their caregivers are no longer considered criminals under federal law. They have federal rights.”
By Steph Sherer, Americans for Safe Access
The Department of Justice and Drug Enforcement Administration’s rescheduling of cannabis is more than just validation for the millions of Americans who rely on cannabis medicines. It is a legal platform for the restoration of their federal rights and privileges.
In light of the changes announced last week, federal policies limiting access to medical cannabis and federal services are not just discriminatory; many are now in violation of the Americans with Disabilities Act (ADA) and the Fair Housing Act (FHA).
Medical cannabis advocates are elated to see federal recognition of their medicine, protected patient access and movement toward healthcare integration—concepts that we have fought for decades to realize. The DOJ order moves the country closer to those goals by recognizing “marijuana products regulated by qualifying state medical cannabis licenses” as falling within Schedule III, rather than Schedule I.
These products are now federally recognized as legitimate medicine.
For years, courts and federal agencies have upheld discrimination against medical cannabis patients by pointing to the Schedule I status of
Read full article on Marijuana Moment
